Search Browse Earnings

Septerna, Inc. — SlamSEC

Septerna, Inc.

Nasdaq:SEPN

Pharmaceutical Preparations·SOUTH SAN FRANCISCO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$1.1M

+611.9% YoY

FY 2025

Adj. EBITDA

-$79.4M

-7388.2% margin

FY 2025

Net Income

-$71.8M

-6678.9% margin

FY 2025

EPS (Diluted)

-$7.26

FY 2025

Stock Price

$26.45

+0.5%

2026-03-12

52W Range

$4.66 – $32.63

P/E Ratio

-3.6x

Market Cap

$1.2B

Cash

$238.2M

FY 2025

Total Debt

—

Net Cash

$238.2M

FY 2025

Enterprise Value

$949.4M

Debt / EBITDA

3.0x

FY 2025

EV / EBITDA

-12.0x

Employees

—